Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From exile to medal: psychosocial wellbeing, belonging, and global solidarity in the Refugee Olympic Team through an ACTM perspective.

Frontiers in psychology·2026
Same author

Left ventricular recovery and outcomes in patients with a durable left ventricular assist device: the EUROMACS registry.

European heart journal·2026
Same author

Timing of spontaneous breathing in veno-venous extracorporeal membrane oxygenation: An exploratory analysis of intensive care outcomes.

Journal of critical care·2026
Same author

Cancer Therapy-Related Cardiac Dysfunction: Pooled Incidence of Subclinical and Clinical Presentations Using Multimodal Multi-Parametric Imaging-A Systematic Review and Meta Analysis.

Journal of clinical medicine·2026
Same author

The Diagnostic Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Infections in Patients With Left Ventricular Assist Device.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Impact of Delayed Heparin Bridging on Bleeding and Stroke After Left Ventricular Assist Device Implantation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026

Related Experiment Video

Updated: Jun 27, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K

Temporary Right-Ventricular Assist Devices: A Systematic Review.

Mahmoud Abdelshafy1,2, Kadir Caliskan3, Goksel Guven4,5

  • 1Discipline of Cardiology, Saolta Group, Galway University Hospital, Health Service Executive and CORRIB Core Lab, National University of Ireland Galway (NUIG), H91 V4AY Galway, Ireland.

Journal of Clinical Medicine
|February 15, 2022
PubMed
Summary

Temporary right-ventricular assist devices (t-RVADs) offer a life-saving option for severe right-sided heart failure (RHF). While outcomes vary, t-RVADs show potential despite limited evidence from heterogeneous studies.

Keywords:
efficacyright-sided heart failuresafetysystematic reviewtemporary right ventricular assist device

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.0K

Related Experiment Videos

Last Updated: Jun 27, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.0K

Area of Science:

  • Cardiology
  • Medical Devices
  • Clinical Research

Background:

  • Acute right-sided heart failure (RHF) presents complex clinical challenges with limited evidence.
  • Severe right-ventricular dysfunction necessitates advanced treatment options.

Purpose of the Study:

  • To systematically review the safety and efficacy of temporary right-ventricular assist device (t-RVAD) implantation.
  • To evaluate t-RVAD as a bridge-to-recovery or permanent solution for RHF.

Main Methods:

  • Systematic review of 31 studies meeting inclusion criteria.
  • Data extraction on t-RVAD implantation, outcomes, and complications.

Main Results:

  • Successful t-RVAD weaning rates varied widely (23%-100%).
  • 30-day survival post-implantation ranged from 46% to 100%.
  • Common complications included bleeding, acute kidney injury, stroke, and device malfunction.

Conclusions:

  • t-RVAD is a potentially life-saving intervention for severe RHF, despite variable outcomes.
  • Evidence is limited to small, non-randomized, heterogeneous studies.
  • Standardized trial methodology and technological advancements are needed for t-RVAD therapy.